There are some potential biomarkers able to identify a subset of diabetic patients with PAD more prone to suffer major amputations; for instance, the tumor necrosis factor receptor 1 (TNFR1) has been associated with major amputation outcome [41]. The gene discussed is TNFRSF1A; the disease is peripheral arterial disease.